Anticorps Monoclonal anti-SPINT1/HAI-1
SPINT1/HAI-1 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
WB, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
2H2D8
N° de cat : 67031-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
67031-1-PBS cible SPINT1/HAI-1 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Mouse / IgG1 |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | SPINT1/HAI-1 Protéine recombinante Ag26733 |
| Nom complet | serine peptidase inhibitor, Kunitz type 1 |
| Masse moléculaire calculée | 58 kDa |
| Poids moléculaire observé | 58 kDa |
| Numéro d’acquisition GenBank | BC004140 |
| Symbole du gène | HAI-1 |
| Identification du gène (NCBI) | 6692 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine G |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is also named as SPINT1 and Kunitz-type protease inhibitor 1. HAI-1 is critical to control matriptase proteolytic activity (PMID: 25310042). HAI-1 inhibits matriptase activity through forming complex with activated matriptase (PMID: 30370662). matriptase, HAI‐1 also binds to and inhibits a variety of serine proteases including of hepsin, plasmin, prostasin, TMPRSS13 and HAT. HAI-1 as a cell-autonomous tumor suppressor that negatively regulates the HGF pathway (PMID: 25925948). HAI-1 is inhibitor of HGFAC (PMID: 9045658). HAI-1 inhibits serine protease activity of ST14/matriptase in vitro (PMID: 28710277). HAI-1 inhibits serine protease activity of TMPRSS13, via the BPTI/Kunitz inhibitor 1 domain (PMID: 20977675). HAI-1 expression is reduced in many cancer types, which is implicated in the progression of cancer and is associated with a worse prognosis in cancer patients (PMID: 30370662).



